Xia Wang

Xia Wang

Auto-generated profile, based on publicly available information

Xia Wang

College of Animal Science and Technology, Gansu Agricultural University, Lanzhou 730070, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2006 in Cancer Research
Verified
Journal Article
Closed access
PDF file
XWXia Wang
Xia Wang
WJWei Ju
Wei Ju
JRJordan Renouard
Jordan Renouard
JAJames Aden
James Aden
SBSteven Belinsky
Steven Belinsky
YLYong Lin
Yong Lin
Nuclear factor-κB (NF-κB), a survival signal induced by tumor necrosis factor (TNF), contributes substantially to the resistance to TNF-induced cell death. Previous studies suggest that heat shock protein 90 (Hsp90) regulates the stability and function of receptor-interaction proteins (RIP) and IκB kinase β (IKKβ), the key components of the TNF-induced NF-κB activation pathway. In this study, we showed that the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG) was synergistic with TNF to induce apoptotic cell death in a panel of lung tumor-derived cell lines. Treatment with 17AAG caused degradation of RIP and IKKβ that, in turn, blocked TNF-induced NF-κB activation and antiapoptotic gene expression. The synergistic cytotoxicity was detected only when TNF treatment followed 17AAG preexposure. Importantly, the potentiation of cell death was abolished in NF-κB-disabled cells that express a nondegradable IκBα mutant (IκBαAA). These results suggest that the cytotoxicity seen with 17AAG and TNF treatment results from blocking TNF-induced NF-κB activation. The other components of the TNF receptor I signaling cascade were not altered, whereas TNF-induced c-Jun NH2-terminal kinase activation and apoptosis were potentiated. A similar synergism for inducing apoptosis was also observed in 17AAG-treated and TNF-related apoptosis-inducing ligand (TRAIL)–treated cancer cells. Our results suggest that NF-κB plays a key role in the resistance of lung cancer cells to TNF and TRAIL and that disabling this survival signal with 17AAG followed by TNF or TRAIL treatment could be an effective new therapeutic strategy for lung cancer. (Cancer Res 2006; 66(2): 1089-95)

1 November 2020 in Gene
Verified
Journal Article
Closed access
XWXia Wang
Xia Wang
TLTaotao Li
Taotao Li
DYDe'EN Yin
De'EN Yin
NCNana Chen
Nana Chen
XAXuejiao An
Xuejiao An
YMYouji Ma
Youji Ma